z-logo
open-access-imgOpen Access
Long-term efficacy and safety of treatment with nevirapine plus nucleoside reverse transcriptase inhibitors for HIV-1 infection: An eight-years follow-up
Author(s) -
Canio Martinelli,
Paola Corsi,
Maurizio Mena,
Antonio Carocci
Publication year - 2012
Publication title -
hiv and aids review
Language(s) - English
Resource type - Journals
eISSN - 1732-2707
pISSN - 1730-1270
DOI - 10.1016/j.hivar.2012.08.002
Subject(s) - nevirapine , medicine , nucleoside reverse transcriptase inhibitor , dyslipidemia , viral load , reverse transcriptase inhibitor , reverse transcriptase , gastroenterology , liver enzyme , nucleoside analogue , retrospective cohort study , liver function , toxicity , efavirenz , drug , antiretroviral therapy , human immunodeficiency virus (hiv) , nucleoside , pharmacology , immunology , biology , rna , biochemistry , gene , obesity

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom